Regulations
Current Regulations
Third (Final) Version of RegulationsDraft (Posted July 17, 2023)
- COMAR 14.01.01.01 – General Provisions (Definitions) (Third Draft)
- COMAR 14.01.01.01 – General Provisions (Definitions) (Redlined)
- COMAR 14.01.01.02-.03 – General Provisions (Rules of Construction, Open Meetings) (Third Draft)
- COMAR.01.01.02-.03 – General Provisions (Rules of Construction, Open Meetings) (Redlined)
- COMAR 14.01.01.04 – General Provisions (Confidential, Trade-Secret, and Proprietary Information) (Third Draft)
- COMAR. 14.01.0.1.04 – General Provisions (Confidential, Trade-Secret and Proprietary Information) (Redlined)
- COMAR 14.01.01.05- Public Comment Process (New)
- COMAR 14.01.04.01-05 – Cost Review Study Process (Third Draft)
- COMAR 14.01.04.01-05 – Cost Review Study Process (Redlined)
COMMENT PERIOD CLOSED: June 30, 2023 (Posted: June 16, 2023)
COMAR 14.01.01.01 – General Provisions (Definitions) (Second Draft)
COMAR 14.01.01.01 – General Provisions (Definitions) (Redlined)
COMAR 14.01.01.02-.03 – General Provisions (Rules of Construction, Open Meetings) (Second Draft)
COMAR.01.01.02-.03 – General Provisions (Rules of Construction, Open Meetings) (Redlined)
COMAR 14.01.04.01-05 – Cost Review Study Process (Second Draft)
COMAR 14.01.04.01-05 – Cost Review Study Process (Redlined)
Comments Received
- Arthritis Foundation and Attachment (Value in the States Principles)
- Biotechnology Innovation Organization (BIO)
- Healthcare Distribution Alliance
- Jane Horvath
- Jim Gutman
- Kaiser Permanente
- Maryland Tech Council
- PhRMA
Draft Regulations for Consideration at May 22, 2023 Board Meeting (Posted May 15, 2023)
COMAR 14.01.02.02-.03 – Prescription Drug Affordability Fund (Second Draft)
COMAR 14.01.02.02-.03 – Prescription Drug Affordability Fund (Redlined)
COMAR 14.01.03 Public Information Act (Second Draft)
COMAR 14.01.03 Public Information Act (Redlined)
COMMENT PERIOD CLOSED MAY 5, 2023 (Posted on April 24, 2023)
COMAR 14.01.01.02- Rules of Construction (First Draft)
COMAR 14.01.04.01- Public Information Act (First Draft)
COMAR 14.01.01.04 – Confidential, Trade-Secret, and Proprietary Information (First Draft)
COMMENT PERIOD CLOSED MAY 2, 2023 (Posted on April 11, 2023)
COMAR 14.01.01.01 – General Provisions (Definitions- NEW) (First Draft)
COMAR 14.01.02.02 – Prescription Drug Affordability Fund (First Draft)
COMAR 14.01.03.01-05 – Cost Review Process (First Draft)
Received Comments
- ACLI and The League of Life and Health Insurers of Maryland
- BioTechnology
- Boehringer Ingelheim
- CareFirst
- Healthcare Distribution Alliance (cost review)
- Healthcare Distribution Alliance (PIA)
- Healthcare for All
- Jane Horvath
- Jim Gutman
- Kaiser Permanente
- Maryland Tech Council
- Partnership to Improve Patient Care
- PhRMA (cost review)
- PhRMA (PIA)
- PhRMA (Rules of Construction)
- PhRMA (Confidential, Trade-Secret- Proprietary)